Table 1. Clinical characteristics of deceased COVID-19 patients.

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6	Patient 7	Patient 8	Patient 9	Patient 10	Patient 11
Sex	m	m	m	m	m	m	m	f	f	f	f
Age [years]	82	66	78	54	80	64	64	87	83	85	52
BMI [kg/m²]	23.8	31.5	25.2	28.3	28.8	35.4	24.6	24.6	28.9	26.2	21.4
Pre-existing medical conditions	AF, DM,autoimmune pancreatitis,purpura pigmentosa	aHT	aHT, DM, CRF, PAD, urosepsis shortly before COVID-19	None known	DM, CRF, CHF	GPA, CRF, COPD, aHT, AF, DM	AS, COPD	CHF, CRF, DM, past stroke epilepsy,erysipelasshortly before COVID-19	aHT, DM, CRF, 1-vessel-CHD, AF, PAD	CHF, CRF, DM	Cervical carcinoma
Hospitalization [d]	7	5	30	10	9	20	15	12	7	9	4
ICU [d]	7	5	7	8	8	17	9	0	0	0	4
Mechanical ventilation [d]	7	4	7	7	8	16	9 (ECMO)	0	0	0	0
Antiviral drugs	Lopinavir, ritonavir	Lopinavir, ritonavir	None	None	None	Lopinavir, ritonavir	Lopinavir, ritonavir	None	None	None	None
Cause of death (acc. to clinic)	MOF	Pulmonary embolism	MOF	Lung failure	Suspected myocardial infarction	Lung failure	Lung failure	Respiratory failure	Pneumonia	Pneumonia	Ileus

aHT – arterial hypertension, AF – atrial fibrillation, AS – atherosclerosis, CHF – chronic heart failure, CHD – coronary heart disease, COPD – chronic obstructive pulmonary disease, CRF – chronic renal failure, DM – diabetes mellitus, ECMO - Extracorporeal membrane oxygenation, f – female, GPA – granulomatosis with polyangiitis (Wegener’s Granulomatosis), ICU – intensive care unit, MOF – multiple organ failure, PAD – peripheral artery disease.